SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a crypto emphasizing community, culture, and freedom within the cannabis space. Community members highlight Weedcoin as more than just a token, but a movement to connect people and ideas. With the hashtags #Weedcoin #CryptoCulture #Growth, the community is focused on building a positive and inclusive environment.

Aventus Network

Aventus Network ($AVT.X) is trending as traders discuss its potential for a breakout, pointing to its strong chart setup and real-world partnerships. Community members are drawn to its low market cap, integration with Polkadot, and enterprise use cases, suggesting it may be undervalued. Volume is a key point of focus, as traders anticipate it could drive significant price movement.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around the meme coin, emphasizing its resilience and active development team.  With mentions of breaking all-time highs and a recent listing, the community expresses strong bullish sentiment and encourages others to load up.  The coin's connection to the Solana ecosystem is also a key point of discussion.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics ($AVTX) is trending as investors discuss its potential following a disappointing report from MoonLake ($MLTX), which some believe makes $AVTX's data more interesting. The community is also actively discussing the high option prices and recent insider buying, with some anticipating a potential short squeeze due to the stock's low float and high short interest. Bullish sentiment is further fueled by analysts' Buy ratings and price target increases, focusing on the potential of AVTX-009 in treating hidradenitis suppurativa (HS).

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Illumina Inc

ILMN is trending amid discussions around potential acquisitions, particularly Quantum-Si ($QSI), as a strategic expansion into proteomics following the SomaLogic deal. Community interest is fueled by speculation of an upcoming announcement and bullish sentiment reflected in options activity, though some analysts debate its valuation relative to competitors in the precision oncology market. Broader discussions cover AI applications in genomics and potential catalysts that could drive significant growth for the company.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending due to investor anticipation surrounding upcoming Phase 2 clinical data for its cystic fibrosis (CF) program, with the community hoping for positive results that could challenge Vertex's dominance in the CF treatment market. Additionally, the stock is reacting to analyst ratings and discussion of revenue potential from their COVID vaccine, Kostaive, particularly in the EU and Japan. Community members are also discussing a recent lawsuit, potential future catalysts, and potential short squeeze scenarios.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to positive Phase 3 trial results for its oral Wegovy pill, showing similar weight loss to the injectable version and potentially expanding market reach. The community is discussing the implications for market share and competition with Eli Lilly, especially with FDA approval expected soon. News of the trial results is driving optimism and renewed interest in NVO's potential.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang ($EH) is trending due to anticipation surrounding its VT35 eVTOL launch and recent partnerships, including one with Reignwood Aviation. Community discussions revolve around the company's potential in the urban air mobility sector, with some highlighting its progress relative to competitors. Bullish sentiment is fueled by potential for expansion and speculation around positive catalysts.

Welltower, Inc. is a health care infrastructure company, which engages in seniors housing operations, post-acute providers and health systems to fund the real estate infrastructure. The company's operating business segments include Seniors Housing Operating, Triple-Net, and Outpatient Medical. The Seniors Housing Operating segment operates properties including seniors apartments, independent living and independent supportive living, continuing care retirement communities, and assisted living, Alzheimer's dementia care and includes care homes with or without nursing. The Triple-Net segment properties offer services including independent living & supportive living (Canada), assisted living, continuing care retirement communities, Alzheimer's/dementia care and care homes with or without nursing (U.K.), and long-term/post-acute care. The Outpatient Medical segment invests in and operates outpatient medical buildings including physician offices, ambulatory surgery centers, diagnostic facilities, outpatient services and/or labs. The company was founded in 1970 and is headquartered in Toledo, OH.

Welltower Inc.

WELL is trending due to unusual options activity and analyst ratings updates, with Keybanc recently upgrading the stock to Overweight. Community members are actively discussing the potential for an impulse rally and price target levels based on Elliott Wave analysis. Some analysts highlight tailwinds from a growing senior population and rising healthcare costs, while others point to rate pressures and dividend coverage concerns.

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. is trending due to an upcoming reverse stock split, leading to concerns and discussions about potential dilution and the CEO's past actions. The community expresses frustration and distrust, with some suggesting potential strategies for trading around the split. Despite some positive news and contracts, investors are wary, and the stock's future is uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LaCroix Does it Again . . . Game-Changing Event #2!

LaCroix Sparkling Water by National Beverage Corp. (NASDAQ: FIZZ) today introduced its newest game-changing event . . . a new methodology of innovation . . . Sunshine! This press release features...

LaCroix Partners with WNBAs Indiana Fever

LaCroix Sparkling Water by National Beverage Corp. (NASDAQ: FIZZ) is proud to announce a multi-year partnership with the Indiana Fever Women's National Basketball Association (WNBA) team. The...

National Beverage Corp. Reports Continued Earnings Growth

National Beverage Corp. (NASDAQ: FIZZ) today announced results for its second quarter and six-month periods ended October 26, 2024. Compared to the prior year- Second Quarter: Net sales were $291...

National Beverage Corp. Reports Outstanding First Quarter... The Summer of FIZZ

National Beverage Corp. (NASDAQ: FIZZ) today announced results for its first quarter ended July 27, 2024. Compared to the prior year: This press release features multimedia. View the full release...

Score! LaCroix Partners with the Kansas City Current

LaCroix Sparkling Water by National Beverage Corp. (NASDAQ: FIZZ) is proud to announce its new multi-year partnership with the Kansas City Current, a womens professional soccer team led by the...

LaCroixs Newest Flavor Elicits . . . Delightful Sips of Bliss!! Strawberry Peach to Launch at Select Retailers

LaCroix Sparkling Water by National Beverage Corp. (NASDAQ: FIZZ) today introduced its newest flavor innovation . . . Strawberry Peach! This press release features multimedia. View the full release...

National Beverage Corp. Reports Record Fourth Quarter and Fiscal Year-end Results...Corporate Endorphins at Work

National Beverage Corp. (NASDAQ: FIZZ) today announced results for its fourth quarter and fiscal year ended April 27, 2024. Our recent disclosures and this earnings report confirm that a new and more...

National Beverage Corp. Announces LaCroix Partnership with Inter Miami CF

National Beverage Corp. (NASDAQ: FIZZ) today announced its LaCroix brand has been named the official sparkling water of Inter Miami CF, the top-ranked Major League Soccer (MLS) team. This...

LaCroix Kicks Off Partnership With San Diego Wave FC

LaCroix Sparkling Water by National Beverage Corp. (NASDAQ: FIZZ) is proud to announce its exciting new multi-year partnership with San Diego Wave FC. LaCroix, the premium domestic sparkling water...

National Beverage Corp. Makes High Goals . . . Higher! Declares Special Cash Dividend

National Beverage Corp. (NASDAQ: FIZZ), honoring its committed goal to shareholders, today announced that its Board of Directors has declared a special cash dividend of $3.25 per share to...

National Beverage Corp. engages in the development, manufacture, market, and sale of sparkling waters, juices, energy drinks, and carbonated soft drinks. Its brands include LaCroix, LaCroix Cúrate, LaCroix NiCola, Clear Fruit, Rip It, Everfresh, Everfresh Premier Varietals, Mr. Pure, Shasta, and Faygo. The company was founded by Nick A. Caporella on November 5, 1985 and is headquartered in Fort Lauderdale, FL.

National Beverage Corp.

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$37.09
Prev Close	$36.54
Open	$36.54
Dividend Yield	0.00%
50-Day Moving Average	$43.02
Beta	0.39
Avg. Volume	157,107.86
PE Ratio	18.70

52-Week High	$50.51
52-Week Low	$36.27
Market Capitalization	$3.47B
EPS (Annual)	$1.99
Price to Book	6.89
Revenue Per Employee	$714,666.27
Enterprise Value/EBITDA	N/A

FIZZ
National Beverage Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FIZZ News